Clinical Trial Update: Bortezomib Plus Prednisone for Initial Therapy of Chronic Graft Versus Host Disease [Phase 2]

View source ↗

Summary

This phase 2 clinical trial evaluates the use of bortezomib plus prednisone as initial therapy for chronic graft-versus-host disease and reports the results of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Bortezomib (Velcade) (Bortezomib)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Chronic Graft Versus Host Disease | Phase 2 | Status: COMPLETED | Results posted: 2014-02-28